Forbion Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 31

Professionals

  • Investments
  • 192

  • Portfolio
  • 44

  • Exits
  • 87

Exits

Forbion General Information

Company Description

Founded in 2006, Forbion is a venture capital firm based in Naarden, Netherlands. The firm prefers to invest in companies operating in the medicine and life sciences sectors.

Business Details

Website
www.forbion.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Trade Association
Dutch Venture Capital Association (NVP)
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Corporate Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
+31 035 000 0000

Forbion Investments & Acquisitions (192)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Capstan Therapeutics 20-Mar-2024 Early Stage VC 00000 Biotechnology Pre-Clinical Trials 00000 0ü000000 00.0
Engrail Therapeutics 14-Mar-2024 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 000000 000 00.0
Orbis Medicines 29-Feb-2024 0000 00000 000.00 Drug Discovery Generating Revenue 0000000 00000 00.0
Enterprise Therapeutics 30-Jan-2024 00000 00000 0000 Drug Discovery Generating Revenue 00000-000 000000 00
Calluna Pharma 23-Jan-2024 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 0000000 000000000 000000 00.0
Calluna Pharma 22-Jan-2024 000000 00 00 Drug Discovery Clinical Trials - Phase 2
VectorY Therapeutics 13-Nov-2023 00000 00000 00000 Drug Discovery Pre-Clinical Trials 000000 0000000
Kynexis 07-Nov-2023 00000 00000 000.00 Drug Discovery Startup 00000 00000000 00
Aiolos Bio 24-Oct-2023 Early Stage VC 00000 Biotechnology Generating Revenue 000000 0000000
Tessellate Bio 17-Oct-2023 Seed Round 00.000 Biotechnology Generating Revenue 000000 0000000000 00.0
You’re viewing 10 of 192 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Forbion Exits (87)

Company Name Exit Date Exit Type Exit Size
Aiolos Bio 15-Feb-2024 Merger/Acquisition 00.00
Oxitope Pharma 22-Jan-2024 000000000000000000
Dyne Therapeutics 05-Jan-2024 000000 0000000000 00000
Forbion European Acquisition 01-Nov-2023 000000000000000000
Inversago Pharma 08-Sep-2023 000000000000000000 00.000
Versanis Bio 14-Aug-2023 000000000000000000 00.000
VectivBio 29-Jun-2023 000000000000000000 00.000
NewAmsterdam Pharma 08-Jun-2023 000000000 00000000 00000
Replimune 12-Dec-2022 Public Investment 2nd Offering 00000
Gyroscope 17-Feb-2022 Merger/Acquisition 00.00
You’re viewing 10 of 87 exits. Get the full list »

Forbion Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Forbion‘s full profile, request access.

Request a free trial

Forbion Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Forbion Management, Team & Partners (66)

Name Title Deals Funds Boards Office
Vincent Van Houten Chief Financial Officer & General Partner 0 0 Naarden, Netherlands
Geert-Jan Mulder MD Co-Founder & Managing Partner 00 0 0 Naarden, Netherlands
Martien van Osch Co-Founder & Managing Partner 00 0 Naarden, Netherlands
Sander Slootweg Co-Founder & Managing Partner 0 0 0 Naarden, Netherlands
Holger Reithinger Ph.D General Partner 00 0 0 Munich, Germany
You’re viewing 5 of 66 team members. Get the full list »

Forbion Co-Investors (146)

Name With Exits Lead Partner Series Industry
Atlas Venture 7 0 00 Series chart Industry bar
BioGeneration Ventures 0 00 Series chart Industry bar
RA Capital Management 0 0 00 Series chart Industry bar
Novartis Venture Fund 0 0 Series chart Industry bar
Novo Holdings 0 00 Series chart Industry bar
You’re viewing 5 of 146 co-investors. Get the full list »

Forbion FAQs

  • What is Forbion?

    Founded in 2006, Forbion is a venture capital firm based in Naarden, Netherlands.

  • When was Forbion founded?

    Forbion was founded in 2000.

  • Who is the founder of Forbion?

    Geert-Jan Mulder MD, Martien van Osch, Sander Slootweg, and Bart Bergstein are the founders of Forbion.

  • Where is Forbion headquartered?

    Forbion is headquartered in Naarden, Netherlands.

  • What is Forbion's total asset value?

    Forbion has around 00.000 in total assets under management.

  • How many investments has Forbion made?

    Forbion has made 192 investments.

  • What has Forbion invested in?

    Forbion has made numerous investments in companies like Capstan Therapeutics, Engrail Therapeutics, and Orbis Medicines within the Biotechnology and Drug Discovery industries.

  • What has Forbion invested in recently?

    Forbion's latest investment was on 20-Mar-2024 in Capstan Therapeutics, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »